US Regulatory Strategy for Biologics & Pharmaceutical Drugs

Course Feature
  • Cost
    Paid
  • Provider
    Udemy
  • Certificate
    Paid Certification
  • Language
    English
  • Start Date
    2017-01-01
  • Learners
    No Information
  • Duration
    No Information
  • Instructor
    Brandon Too
Next Course
4.8
361 Ratings
This course provides a comprehensive overview of US Food & Drug Administration (FDA) regulations for biologics and pharmaceutical drugs. It is beneficial for scientists, physicians, entrepreneurs, public health professionals, industry analysts, consultants, and biomedical students interested in the biotechnology and pharmaceutical industry. Learners will gain an understanding of the importance of FDA regulations for public health, and how to navigate through the FDA regulations to market a biologic or pharmaceutical. They will also develop their ability to conduct regulatory intelligence and develop a regulatory strategic plan. This course is a great opportunity to gain knowledge of the drug development process and the key regulatory steps toward FDA approval.
Show All
Course Overview

❗The content presented here is sourced directly from Udemy platform. For comprehensive course details, including enrollment information, simply click on the 'Go to class' link on our website.

Updated in [July 27th, 2023]

This course provides learners with an understanding of the importance of US Food & Drug Administration (FDA) regulations for public health, and how to navigate through the FDA regulations to market a biologic or pharmaceutical. Participants will gain knowledge of the drug development process and the key regulatory steps toward FDA approval, as well as develop their ability to conduct regulatory intelligence and develop a regulatory strategic plan. This course is beneficial for scientists, physicians, entrepreneurs, public health professionals, industry analysts, consultants, and biomedical students interested in the biotechnology and pharmaceutical industry.

Course Syllabus

Section 1: Welcome & Introduction

Section 2: Pre-Investigational New Drug (Pre-IND) - Preclinical Development

Section 3: Investigational New Drug (IND) - Clinical Development

Section 4: New Drug Application - Getting A Drug Approved

Section 5: Post-Approval - Marketed Drug

Section 6: Course Wrap-Up

Show All
Recommended Courses
free birth-of-a-drug-12921
Birth of a drug
4.5
OpenLearn 67 learners
Learn More
Discover the fundamentals of Birth of a drug
free pharmacology-12922
Pharmacology
4.5
Youtube 422 learners
Learn More
Gain an introduction to Pharmacology
free technology-for-continuous-production-of-medicines-12923
Technology for Continuous Production of Medicines
3.0
Edx 240 learners
Learn More
Continuous manufacturing is a process that allows for the continuous production of medicines. It increases productivity and flexibility for companies, as well as providing advantages such as improved quality control and reduced costs. Technologies such as automation and robotics are used to control the process, and ensure that the medicines produced are of the highest quality. Continuous manufacturing is becoming increasingly popular in the pharmaceutical industry.
free foundations-of-originator-and-biosimilar-biologics-for-patients-and-caregivers-12924
Foundations of Originator and Biosimilar Biologics: for Patients and Caregivers
2.0
Edx 100 learners
Learn More
This course provides patients and caregivers with an understanding of originator and biosimilar biologics. It covers topics such as the similarities and differences between originator and biosimilar biologics, the safety and efficacy of biosimilars, and the potential benefits of using biosimilars. Participants will gain the knowledge and skills necessary to make informed decisions about their healthcare.
Favorites (0)
Favorites
0 favorite option

You have no favorites

Name delet
arrow Click Allow to get free US Regulatory Strategy for Biologics & Pharmaceutical Drugs courses!